These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37164265)
1. Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral Leukoplakia. Cai X; Li L; Yu F; Guo R; Zhou X; Zhang F; Zhang H; Zhang J; Li T Lab Invest; 2023 Aug; 103(8):100173. PubMed ID: 37164265 [TBL] [Abstract][Full Text] [Related]
2. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma. Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211 [TBL] [Abstract][Full Text] [Related]
3. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia. Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281 [TBL] [Abstract][Full Text] [Related]
4. Identification of genomic alteration and prognosis using pathomics-based artificial intelligence in oral leukoplakia and head and neck squamous cell carcinoma: A multicenter experimental study. Cai XJ; Peng CR; Cui YY; Li L; Huang MW; Zhang HY; Zhang JY; Li TJ Int J Surg; 2024 Sep; ():. PubMed ID: 39248300 [TBL] [Abstract][Full Text] [Related]
5. DEC1: a potential biomarker of malignant transformation in oral leukoplakia. Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762 [TBL] [Abstract][Full Text] [Related]
6. Expression of Ki-67, Cyclin D1, P53, and P16 in patients with oral leukoplakia and leukoplakia cancerization with spicy diet in Chengdu. Wan ZX; Zheng ZJ; Huang MC; Chen Y; Yao LH Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):434-440. PubMed ID: 34409799 [TBL] [Abstract][Full Text] [Related]
7. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes. Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907 [TBL] [Abstract][Full Text] [Related]
8. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China. Li J; Liu Y; Zhang H; Hua H Oral Dis; 2020 Oct; 26(7):1402-1413. PubMed ID: 32348606 [TBL] [Abstract][Full Text] [Related]
9. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation. Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687 [TBL] [Abstract][Full Text] [Related]
10. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia. Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621 [TBL] [Abstract][Full Text] [Related]
11. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers. Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449 [TBL] [Abstract][Full Text] [Related]
12. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma. Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018 [TBL] [Abstract][Full Text] [Related]
13. From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer. Li B; Qin W; Yang L; Li H; Jiang C; Yao Y; Cheng S; Zou B; Fan B; Dong T; Wang L J Transl Med; 2024 Feb; 22(1):195. PubMed ID: 38388379 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for malignant transformation of oral leukoplakia. Li F; Qiu L; Gao Q; Yu L; Liu H; Xue Z; Tao A Genomics; 2023 Sep; 115(5):110686. PubMed ID: 37454941 [TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis. Dong Y; Chen Y; Tao Y; Hao Y; Jiang L; Dan H; Zeng X; Chen Q; Zhou Y Lasers Med Sci; 2019 Feb; 34(1):209-221. PubMed ID: 30443884 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225 [TBL] [Abstract][Full Text] [Related]
17. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919 [TBL] [Abstract][Full Text] [Related]
18. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma]. Cao J; Jin JQ; Deng DJ; Liu HW Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914 [TBL] [Abstract][Full Text] [Related]
19. Autofluorescence imaging as a noninvasive tool of risk stratification for malignant transformation of oral leukoplakia: A follow-up cohort study. Li C; Zhang Q; Sun K; Jia H; Shen X; Tang G; Liu W; Shi L Oral Oncol; 2022 Jul; 130():105941. PubMed ID: 35653817 [TBL] [Abstract][Full Text] [Related]
20. Role of the human papillomavirus in malignant transformation of oral leukoplakia distinct from oropharyngeal squamous cell carcinoma: A study of 76 patients with internal-control specimens. Wu W; Wang Z; Zhou Z Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Sep; 128(3):273-279. PubMed ID: 31133518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]